Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Sci Rep ; 14(1): 8762, 2024 04 16.
Artículo en Inglés | MEDLINE | ID: mdl-38627442

RESUMEN

Metastatic colorectal cancer (CRC) is still in need of effective treatments. This study applies a holistic approach to propose new targets for treatment of primary and liver metastatic CRC and investigates their therapeutic potential in-vitro. An integrative analysis of primary and metastatic CRC samples was implemented for alternative target and treatment proposals. Integrated microarray samples were grouped based on a co-expression network analysis. Significant gene modules correlated with primary CRC and metastatic phenotypes were identified. Network clustering and pathway enrichments were applied to gene modules to prioritize potential targets, which were shortlisted by independent validation. Finally, drug-target interaction search led to three agents for primary and liver metastatic CRC phenotypes. Hesperadin and BAY-1217389 suppress colony formation over a 14-day period, with Hesperadin showing additional efficacy in reducing cell viability within 48 h. As both candidates target the G2/M phase proteins NEK2 or TTK, we confirmed their anti-proliferative properties by Ki-67 staining. Hesperadinin particular arrested the cell cycle at the G2/M phase. IL-29A treatment reduced migration and invasion capacities of TGF-ß induced metastatic cell lines. In addition, this anti-metastatic treatment attenuated TGF-ß dependent mesenchymal transition. Network analysis suggests IL-29A induces the JAK/STAT pathway in a preventive manner.


Asunto(s)
Neoplasias del Colon , Neoplasias Colorrectales , Indoles , Neoplasias Hepáticas , Neoplasias del Recto , Sulfonamidas , Humanos , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/patología , Transcriptoma , Quinasas Janus/metabolismo , Transducción de Señal , Factores de Transcripción STAT/metabolismo , Neoplasias del Colon/genética , Neoplasias del Recto/genética , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/secundario , Factor de Crecimiento Transformador beta/metabolismo , Línea Celular Tumoral , Movimiento Celular , Regulación Neoplásica de la Expresión Génica , Quinasas Relacionadas con NIMA/genética
2.
Curr Issues Mol Biol ; 46(3): 1777-1798, 2024 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-38534733

RESUMEN

This paper aims to elucidate the differentially coexpressed genes, their potential mechanisms, and possible drug targets in low-grade invasive serous ovarian carcinoma (LGSC) in terms of the biologic continuity of normal, borderline, and malignant LGSC. We performed a bioinformatics analysis, integrating datasets generated using the GPL570 platform from different studies from the GEO database to identify changes in this transition, gene expression, drug targets, and their relationships with tumor microenvironmental characteristics. In the transition from ovarian epithelial cells to the serous borderline, the FGFR3 gene in the "Estrogen Response Late" pathway, the ITGB2 gene in the "Cell Adhesion Molecule", the CD74 gene in the "Regulation of Cell Migration", and the IGF1 gene in the "Xenobiotic Metabolism" pathway were upregulated in the transition from borderline to LGSC. The ERBB4 gene in "Proteoglycan in Cancer", the AR gene in "Pathways in Cancer" and "Estrogen Response Early" pathways, were upregulated in the transition from ovarian epithelial cells to LGSC. In addition, SPP1 and ITGB2 genes were correlated with macrophage infiltration in the LGSC group. This research provides a valuable framework for the development of personalized therapeutic approaches in the context of LGSC, with the aim of improving patient outcomes and quality of life. Furthermore, the main goal of the current study is a preliminary study designed to generate in silico inferences, and it is also important to note that subsequent in vitro and in vivo studies will be necessary to confirm the results before considering these results as fully reliable.

3.
J Biophotonics ; 17(4): e202300377, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38247032

RESUMEN

This article investigates an endoscopic approach that utilizes negative pressure to achieve laser-induced thermal coagulation limited to the esophageal wall's mucosal and superficial submucosal layers. The study was built upon a series of studies combining numerical simulation based on the Monte-Carlo technique and ex vivo porcine tissue experiments, including apparatus design and histology analysis. An endoscopy apparatus was developed using 3D printing to validate the tissue stretching-based approach. A fiber-pigtailed diode was used as the near-infrared source, emitting 208.8 W/cm2 laser irradiance at 1.5 µm. Simulation results suggested that the approach successfully created a local heat well to prevent residual thermal effects (>65°C) from penetrating the deeper submucosal layer. Histology analysis of ex vivo tissues showed that at a fluence of 5.22 kJ/cm2, the depth of thermal coagulation was reduced by half compared to the control. With further preclinical studies, including endoscopy apparatus design, the approach can be applied to the larger esophageal surface.


Asunto(s)
Terapia por Láser , Animales , Porcinos , Endoscopía , Rayos Láser , Luz , Fototerapia
4.
Cancers (Basel) ; 15(24)2023 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-38136270

RESUMEN

Deregulation of cellular metabolism has recently emerged as a notable cancer characteristic. This reprogramming of key metabolic pathways supports tumor growth. Targeting cancer metabolism demonstrates the potential for managing colorectal cancer. Beta-hydroxybutyrate (BOHB) acts as an acetyl-CoA source for the tricarboxylic acid (TCA) cycle, possibly redirecting energy metabolic pathways towards the TCA cycle that could enhance sensitivity to oxaliplatin, through the generation of reactive oxygen species (ROS). This study explores the potential of BOHB to enhance oxaliplatin's cytotoxic effect by altering the energy metabolism in colorectal cancer. The study employed advanced in vitro organoid technology, which successfully emulates in vivo physiology. The combination treatment efficacy of BOHB and oxaliplatin was evaluated via cell viability assay. The levels of key proteins involved in energy metabolism, apoptotic pathways, DNA damage markers, and histone acetylation were analyzed via Western Blot. ROS levels were evaluated via flow cytometer. Non-toxic doses of BOHB with oxaliplatin significantly amplified cytotoxicity in colorectal cancer organoids. Treatment with BOHB and/or melatonin resulted in significantly decreased lactate dehydrogenase A and increased mitochondrial carrier protein 2 levels, indicating inhibited aerobic glycolysis and an increased oxidative phosphorylation rate. This metabolic shift induced apoptotic cell death mediated by oxaliplatin, owing to high levels of ROS. Melatonin counteracted this effect by protecting cancer cells from high oxidative stress conditions. BOHB may enhance the efficacy of chemotherapeutics with a similar mechanism of action to oxaliplatin in colorectal cancer treatment. These innovative combinations could improve treatment outcomes for colorectal cancer patients.

5.
PLoS One ; 18(5): e0284647, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37195911

RESUMEN

BACKGROUND: The aim of this paper was to evaluate the change in 25-hidroxyvitamin D (25(OH)D) levels before and during the COVID-19 pandemic. METHODS: In this retrospective, cross-sectional and methodological study included 86,772 patients (18-75 years) samples who were admitted to the Izmir Dokuz Eylul University Hospital (latitude and longitude (Turkey): 27 E 09; 38 N 25, respectively) for various reasons and whose 25(OH)D levels were measured in the biochemistry unit between 2019-2020 and 2020-2021 (before and during the COVID-19 outbreak). A time series analysis of monthly averages for 25(OH)D was performed. For the purpose of seasonal study, the mean levels of 25(OH)D are grouped by years. Data were modeled in terms of 25(OH)D levels using the MATLAB Curve Fitting Toolbox. RESULTS: There was no significant difference between the sexes according to 25(OH)D levels (p>0.05). 25(OH)D levels were significantly higher in the summer months and lower in the winter months (p<0.001). When comparing the spring months, 25(OH)D levels in 2020 (18 ± 10) were found to be significantly lower than in 2019 (22 ± 12) (p<0.001); on the contrary, when examined based on the summer, autumn, and winter months, it was determined that 25(OH)D levels increased in 2020 (summer: 25 ± 13, autumn: 25 ± 14, and winter: 19 ± 10) compared to 2019 (summer: 23 ± 11, autumn: 22 ± 10, and winter: 19 ± 11) (p<0.001). In the estimates curve obtained with an error margin of 11% in the time series analysis, it was estimated that the 25(OH)D averages after the pandemic would be similar to those before the pandemic. CONCLUSIONS: Restrictions, partial or complete closures, and curfews can significantly affect individuals' 25(OH)D levels during the COVID-19 outbreak. There is a need for multicenter studies with larger populations covering different regions to strengthen and support our results.


Asunto(s)
COVID-19 , Deficiencia de Vitamina D , Humanos , Estudios Transversales , Pandemias , Estudios Retrospectivos , COVID-19/epidemiología , Vitamina D , Calcifediol , Deficiencia de Vitamina D/epidemiología , Estaciones del Año
6.
Arab J Gastroenterol ; 24(2): 91-97, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-36720664

RESUMEN

BACKGROUND AND STUDY AIMS: Intestinal metaplasia (IM), and Helicobacter pylori (HP) infection can be shown as risk factors in the development of gastric cancer (GC). WNT signaling pathway plays a critical role in carcinogenesis. However, the literature studies are limited on the significance of this pathway for the transition from IM to GC. PATIENTS AND METHODS: We aimed to investigate the importance of the genes of WNT signaling pathways diagnostic and prognostic markers in the presence and absence of HP in conversion from IM to GC. 104 patients, (GC group n = 35, IM group n = 45, control group n = 25) were included in this case-control study. Expression of genes in WNT signalling were searched in study groups with qRT-PCR array and qRT-PCR method. Data were analysed using PCR array data analysis software. RESULTS: Statistically significant overexpression of RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes was detected in the GC and IM groups compared to the control group (p < 0.05). Statistically significant overexpression of RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes was observed in patients with metastatic GC compared to patients with GC without metastasis (p < 0.05). It was found that the RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes were statistically significantly over-expressed in diffuse GC patients compared to non-diffuse GC patients (p < 0.05). Statistically significant overexpression of RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes was detected in HP positive IM patients compared to HP negative IM patients (p < 0.05). CONCLUSION: Overexpression of RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes in IM may suggest that these genes are important markers in the development of IM and inflammation with HP. In addition, these genes are linked to tumor burden in the GC group. Consequently, we can conclude that these genes are poor prognosis biomarkers for GC and have the potential to be used as markers for future treatment monitoring.


Asunto(s)
Infecciones por Helicobacter , Helicobacter pylori , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/patología , Mucosa Gástrica/metabolismo , Estudios de Casos y Controles , Factores de Riesgo , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/genética , Proteína de Unión al GTP rhoA/genética , Proteína de Unión al GTP rhoA/metabolismo , Proteína-5 Relacionada con Receptor de Lipoproteína de Baja Densidad/genética , Proteína-5 Relacionada con Receptor de Lipoproteína de Baja Densidad/metabolismo , Proteínas Dishevelled/metabolismo
7.
PLoS One ; 17(4): e0267973, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35486660

RESUMEN

Adenomatous polyps of the colon are the most common neoplastic polyps. Although most of adenomatous polyps do not show malign transformation, majority of colorectal carcinomas originate from neoplastic polyps. Therefore, understanding of this transformation process would help in both preventive therapies and evaluation of malignancy risks. This study uncovers alterations in gene expressions as potential biomarkers that are revealed by integration of several network-based approaches. In silico analysis performed on a unified microarray cohort, which is covering 150 normal colon and adenomatous polyp samples. Significant gene modules were obtained by a weighted gene co-expression network analysis. Gene modules with similar profiles were mapped to a colon tissue specific functional interaction network. Several clustering algorithms run on the colon-specific network and the most significant sub-modules between the clusters were identified. The biomarkers were selected by filtering differentially expressed genes which also involve in significant biological processes and pathways. Biomarkers were also validated on two independent datasets based on their differential gene expressions. To the best of our knowledge, such a cascaded network analysis pipeline was implemented for the first time on a large collection of normal colon and polyp samples. We identified significant increases in TLR4 and MSX1 expressions as well as decrease in chemokine profiles with mostly pro-tumoral activities. These biomarkers might appear as both preventive targets and biomarkers for risk evaluation. As a result, this research proposes novel molecular markers that might be alternative to endoscopic approaches for diagnosis of adenomatous polyps.


Asunto(s)
Pólipos Adenomatosos , Neoplasias Colorrectales , Pólipos Adenomatosos/genética , Pólipos Adenomatosos/patología , Biomarcadores , Estudios de Cohortes , Humanos
8.
Trends Endocrinol Metab ; 32(1): 20-35, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33277157

RESUMEN

Food and nutrition have a profound impact on organismal health and diseases, and tissue-specific adult stem cells play a crucial role in coordinating tissue maintenance by responding to dietary cues. Emerging evidence indicates that adult intestinal stem cells (ISCs) actively adjust their fate decisions in response to diets and nutritional states to drive intestinal adaptation. Here, we review the signaling mechanisms mediating the dietary responses imposed by caloric intake and nutritional composition (i.e., macronutrients and micronutrients), fasting-feeding patterns, diet-induced growth factors, and microbiota on ISCs and their relevance to the beginnings of intestinal tumors.


Asunto(s)
Intestinos/citología , Células Madre/citología , Células Madre/metabolismo , Animales , Carcinogénesis , Neoplasias del Colon/metabolismo , Homeostasis/fisiología , Humanos , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo
9.
Gastroenterol Res Pract ; 2019: 6272098, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31885543

RESUMEN

BACKGROUND: Celiac disease (CD) and inflammatory bowel disease (IBD) involve inflammation of the gastrointestinal lumen, which environmental, genetic, and immunological factors have a role in their pathogenesis. The prevalence of celiac disease in IBD ranges from 0% to 14%. In this study, our aim was to determine the prevalence of CD in IBD patients followed by us who are attending the hospital or outpatient clinic over a period of time of seven years. METHODS: Seven hundred and fifty nine patients (425 M, 334 F, mean age: 46.75, 396 ulcerative colitis (UC), 363 Crohn's disease (CrD)) diagnosed and followed up for IBD between January 2009 and July 2016 were evaluated retrospectively, and clinical, demographic, laboratory, and endoscopic data were collected. RESULTS: CD was investigated in 79 (%10.4) inflammatory bowel disease patients according to symptoms, and in 5.06% (n = 4) of them, we diagnosed CD. The most common indication for investigating for CD was iron deficiency anemia unreponsive to iron supplementation. CONCLUSIONS: We did not find an increased prevalance of celiac disease in Turkish IBD patients in this study. In the presence of refractory iron deficiency anemia without any other cause in IBD patients, investigations for celiac disease should be considered.

10.
Oncol Rep ; 34(4): 1905-14, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26259750

RESUMEN

Ulcerative colitis (UC) is an important risk factor for colorectal cancer (CRC). Histone modifications are one of the epigenetic mechanisms that may have key roles in the carcinogenesis of CRC. At present, there are no studies comparing histone modification patterns of UC and CRC in the literature. Therefore the aim of the present study was to investigate whether genes, particularly those involved in histone modification, have value in patient monitoring with regards to CRC development in UC. Key gene expressions of the histone modification enzyme were assessed and compared in CRC, UC and control groups using the RT-PCR array technique. Patients were divided into subgroups based on the extent and duration of the disease and inflammatory burden, which are considered risk factors for CRC development in UC patients. In UC and CRC groups, a significantly higher overexpression of the NEK6 and AURKA genes compared to the control group was identified. In addition, there was a significantly higher overexpression of HDAC1 and PAK1 genes in the UC group, and of HDAC1, HDAC7, PAK1 and AURKB genes in the CRC group. NEK6, AURKA, HDAC1 and PAK1 were significantly overexpressed in patients with a longer UC duration. Overexpression of AURKA and NEK6 genes was significantly more pronounced in UC patients with more extensive colon involvement. HDAC1, HDAC7, PAK1, NEK6, AURKA and AURKB are important diagnostic and prognostic markers involved in the carcinogenesis of CRC. HDAC1, PAK1, NEK6 and AURKA may be considered as diagnostic markers to be used in CRC screening for UC patients.


Asunto(s)
Aurora Quinasa A/biosíntesis , Biomarcadores de Tumor/biosíntesis , Colitis Ulcerosa/genética , Neoplasias Colorrectales/genética , Proteínas Serina-Treonina Quinasas/biosíntesis , Adulto , Anciano , Aurora Quinasa A/genética , Biomarcadores de Tumor/genética , Transformación Celular Neoplásica/genética , Colitis Ulcerosa/complicaciones , Colitis Ulcerosa/patología , Neoplasias Colorrectales/etiología , Neoplasias Colorrectales/patología , Metilación de ADN/genética , Epigénesis Genética/genética , Femenino , Código de Histonas/genética , Histona Desacetilasa 1/biosíntesis , Histona Desacetilasa 1/genética , Histona Desacetilasas/biosíntesis , Histona Desacetilasas/genética , Humanos , Masculino , Persona de Mediana Edad , Quinasas Relacionadas con NIMA , Proteínas Serina-Treonina Quinasas/genética , Quinasas p21 Activadas/biosíntesis , Quinasas p21 Activadas/genética
11.
Turk J Gastroenterol ; 24(4): 316-21, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24254262

RESUMEN

BACKGROUND/AIMS: Proton-pump inhibitor and ranitidine bismuth citrate-based triple regimens are the two recommended first line treatments for the eradication of Helicobacter pylori. We aimed to compare the effectiveness and tolerability of these two treatments in a prospective, multicentric, randomized study. MATERIALS AND METHODS: Patients with dyspeptic complaints were recruited from 15 study centers. Presence of Helicobacter pylori was investigated by both histology and rapid urease test. The patients were randomized to either ranitidine bismuth citrate 400 mg bid plus amoxicillin 1 g bid plus clarithromycin 500 mg bid (n=149) or lansoprazole 30 mg bid plus amoxicillin 1 g bid plus clarithromycin 500 mg bid (n=130) treatment arm for 14 days. Adverse events have been recorded during the treatment phase. A 13 C urea breath test was performed 6 weeks after termination of treatment to assess the efficacy of the therapy. Eradication rate was calculated by intention-to-treat and per-protocol analysis. RESULTS: Two hundred seventy-nine patients (123 male, 156 female) were eligible for randomization. In per-protocol analysis (n=247), Helicobacter pylori was eradicated with ranitidine bismuth citrate- and lansoprazole-based regimens in 74,6% and 69,2% of cases, respectively (p>0,05). Intention-to-treat analysis (n=279) revealed that eradication rates were 65,1% and 63,6% in ranitidine bismuth citrate and in lansoprazole-based regimens, respectively (p>0,05). Both regimes were well-tolerated, and no serious adverse event was observed during the study. CONCLUSION: Ranitidine bismuth citrate-based regimen is at least as effective and tolerable as the classical proton-pump inhibitor-based regimen, but none of the therapies could achieve the recommendable eradication rate.


Asunto(s)
Amoxicilina/administración & dosificación , Bismuto/administración & dosificación , Dispepsia/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Lansoprazol/administración & dosificación , Ranitidina/análogos & derivados , Adolescente , Adulto , Anciano , Amoxicilina/efectos adversos , Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Bismuto/efectos adversos , Claritromicina/administración & dosificación , Claritromicina/efectos adversos , Esquema de Medicación , Quimioterapia Combinada , Dispepsia/microbiología , Endoscopía del Sistema Digestivo , Femenino , Infecciones por Helicobacter/diagnóstico , Antagonistas de los Receptores H2 de la Histamina/administración & dosificación , Antagonistas de los Receptores H2 de la Histamina/efectos adversos , Humanos , Lansoprazol/efectos adversos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Inhibidores de la Bomba de Protones/administración & dosificación , Inhibidores de la Bomba de Protones/efectos adversos , Ranitidina/administración & dosificación , Ranitidina/efectos adversos , Resultado del Tratamiento , Adulto Joven
12.
Pediatr Hematol Oncol ; 26(1): 57-61, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19206009

RESUMEN

Iron-deficiency anemia due to iron malabsorption and duodenal nodular lymphoid hyperplasia (NLH) has been described in children with Giardia intestinalis infection. Also, symptomatic iron-deficiency anemia is rarely encountered in male adolescents. A 14-year-old boy underwent esophagogastroduodenoscopy for investigation of symptomatic iron-deficiency anemia (hemoglobin 5.8 g/dL, mean corpuscular volume 65.3 fL, serum ferritin < 1.5 ng/mL). He had a sufficient diet for iron and recurrent bouts of diarrhea without melena. At upper endoscopy, duodenal mucosa was diffusely nodular. Histopathologic evaluation of biopsy samples from the duodenum revealed infection with Giardia intestinalis. His anemia improved with metronidazole and iron treatment.


Asunto(s)
Anemia Ferropénica/etiología , Giardiasis/complicaciones , Hiperplasia/etiología , Adolescente , Anemia Ferropénica/complicaciones , Anemia Ferropénica/diagnóstico , Anemia Ferropénica/tratamiento farmacológico , Comorbilidad , Duodeno/patología , Giardiasis/diagnóstico , Humanos , Hiperplasia/complicaciones , Hiperplasia/diagnóstico , Mucosa Intestinal/patología , Hierro/uso terapéutico , Enfermedades Linfáticas/patología , Masculino , Metronidazol/uso terapéutico
13.
Turk J Gastroenterol ; 19(2): 114-6, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19110667

RESUMEN

We report a 65-year-old patient with a gastric polyp of 2.5 cm in diameter located at the cardia on upper gastrointestinal (GI) endoscopy. Pathological examination of the excised polyp showed intramucosal carcinoma. Endoscopic ultrasonography (EUS) reported the lesion as early gastric carcinoma with probable submucosal involvement. On serial sections of the gastrectomy material, the lesion was an intramucosal carcinoma and surprisingly there was a leiomyoma located adjacently.


Asunto(s)
Carcinoma/diagnóstico , Mucosa Gástrica/patología , Leiomioma/diagnóstico , Neoplasias Primarias Secundarias/diagnóstico , Pólipos/diagnóstico , Neoplasias Gástricas/diagnóstico , Pólipos Adenomatosos/diagnóstico , Pólipos Adenomatosos/cirugía , Anciano , Carcinoma/cirugía , Cardias/patología , Cardias/cirugía , Diagnóstico Diferencial , Endoscopía del Sistema Digestivo/métodos , Endosonografía , Femenino , Gastrectomía , Mucosa Gástrica/cirugía , Humanos , Leiomioma/cirugía , Neoplasias Primarias Secundarias/cirugía , Pólipos/cirugía , Neoplasias Gástricas/cirugía
14.
Clin Auton Res ; 18(3): 145-9, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18449593

RESUMEN

Opioid receptors involved in regulating the motility of the gastrointestinal tract have been localized in both contractile and neuronal tissues. Trimebutine, a peripheral opioid receptor agonist, modulates gastrointestinal motor activity in both directions and also may act on cardiac tissue. This study investigated the effects of trimebutine in clinical doses on cardiac autonomic functions with heart rate variability. The effect of trimebutine on cardiac autonomic outflows was evaluated in 11 healthy subjects. Trimebutine (200 mg) or placebo was administered orally at random in a double-blind, cross-over manner. Continuous electrocardiography recordings were obtained before and after drug administration during three states: rest, controlled breathing, and a hand grip exercise. Heart rate variability analysis showed that there was no significant difference between subjects administered with placebo or trimebutine throughout rest, controlled breathing, or the hand grip exercise. We concluded that trimebutine, in clinical doses, has no significant effect on cardiac autonomic functions.


Asunto(s)
Fármacos Gastrointestinales/farmacología , Frecuencia Cardíaca/fisiología , Receptores Opioides/fisiología , Trimebutino/farmacología , Adulto , Sistema Nervioso Autónomo/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Electrocardiografía , Motilidad Gastrointestinal/efectos de los fármacos , Motilidad Gastrointestinal/fisiología , Fuerza de la Mano/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Receptores Opioides/efectos de los fármacos , Mecánica Respiratoria/fisiología
15.
J Obstet Gynaecol Res ; 32(6): 602-4, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17100823

RESUMEN

Diabetes insipidus in pregnancy has different causes. The association of diabetes insipidus with disturbances of liver function has been reported, however, diabetes insipidus has rarely been reported in HELLP syndrome. We present a 23-year-old primigravida with a singleton gestation complicated by HELLP syndrome who developed postpartum diabetes insipidus. Labor was induced promptly to terminate pregnancy because of intrauterine fetal death and liver dysfunction. 1-deamino-8-D-arginine-vasopressin was administered. Diabetes insipidus and liver dysfunction resolved within 2 weeks. Development of diabetes insipidus may result from increased vasopressinase activity mainly caused by deterioration of liver functions caused by HELLP syndrome. In pregnant women with liver disease as a result of any cause, the development of diabetes insipidus should be assessed with particular attention.


Asunto(s)
Fármacos Antidiuréticos/farmacología , Desamino Arginina Vasopresina/farmacología , Diabetes Insípida/etiología , Síndrome HELLP/fisiopatología , Hepatopatías/complicaciones , Adulto , Diabetes Insípida/tratamiento farmacológico , Femenino , Muerte Fetal , Glucocorticoides/farmacología , Síndrome HELLP/terapia , Humanos , Intercambio Plasmático , Periodo Posparto , Embarazo
16.
Saudi Med J ; 27(7): 1022-7, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16830024

RESUMEN

OBJECTIVE: To determine the effect of hospitalization in the internal disease clinics on nutrition variables. METHODS: This study was a cohort-type study performed in the Internal Diseases Clinics, University Hospital in Turkey. We included 208 patients who were hospitalized in the Internal Diseases Clinics of the University between June and August 2003. The clinical nutrition parameters of all the patients were evaluated from anthropometric measurements and laboratory results at admission and discharge. RESULTS: Of 208, 105 were females, and 103 were males. The average age was 57 +/- 13.5 (18-85) years. Average hospitalization period of the cases was 14 +/- 10 (1-73) days. While the average body weight at admission was 71.6 +/- 10.9 kg and it was found to be 70.7 +/- 1.3 kg at discharge (paired sample t test, p<0.001). We noted the statistically significant decrease in the body mass index, waist and hip measures, muscle-skin folds thickness, and body adipose mass (p<0.05). Decreases were observed in all the clinical parameters of laboratory test results of the patients indicating end products of fat, protein, and carbohydrate metabolism (p<0.05). It was observed that the demographic characteristics of the patients (age, gender, occupation, education, and so forth) did not affect the decrease in nutritional parameters (p>0.05). CONCLUSION: It was observed that decreases occurred in all the nutrition parameters of the patients who were hospitalized in the internal diseases clinics. It is suggested that these decreases are related to entire fat, protein, and carbohydrate metabolism. Nutritional parameters of patients should be followed during hospitalization with the purpose of preventing regression in nutrition parameters.


Asunto(s)
Peso Corporal , Hospitalización , Estado Nutricional , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Estudios de Cohortes , Femenino , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Evaluación Nutricional , Turquía
17.
South Med J ; 99(3): 208-11, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16553093

RESUMEN

OBJECTIVE: Sildenafil stimulates the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway through inhibition of type 5 phosphodiesterase. NO-cGMP pathway causes smooth muscle relaxation. The aim of this study is to evaluate the effects of sildenafil on gallbladder motility. METHODS: Twenty healthy male volunteers (21-35 years old) participated in this randomized, double blind, crossover, and placebo-controlled study. Oral sildenafil (50 mg) or placebo was randomly dispensed to each volunteer on two consecutive days. After the sildenafil or placebo, a special meal with a high fat content was administered. Gallbladder volume was measured using sonography preprandially and at 5, 15, 30, 60, 120 and 180 minutes postprandially. RESULTS: Sildenafil showed an inhibitory effect on gallbladder contraction in healthy volunteers that began at 30 minutes. Gallbladder volumes showed significant differences at 30 minutes following the test meal (approximately 50-60 min after the sildenafil intake), between placebo (15.4 +/- 5.1 mL) and the sildenafil groups (19.3 +/- 6.1 mL) (P < 0.05). In addition, gallbladder volume was significantly higher during the refilling phase in the sildenafil group (P < 0.05 at 180 min). Maximal contraction was achieved at 60 minutes in each group. CONCLUSIONS: Sildenafil constituted a significant inhibitory effect on gallbladder discharge in healthy individuals when compared with placebo group. Because of this inhibitory effect, sildenafil consumption for long periods may potentiate risks of gallbladder disorders and gallstone formation resulting from disturbed gallbladder motility.


Asunto(s)
3',5'-GMP Cíclico Fosfodiesterasas/antagonistas & inhibidores , Vaciamiento Vesicular/efectos de los fármacos , Inhibidores de Fosfodiesterasa/administración & dosificación , Piperazinas/administración & dosificación , Periodo Posprandial/efectos de los fármacos , Administración Oral , Adulto , Estudios Cruzados , Método Doble Ciego , Estudios de Seguimiento , Vesícula Biliar/diagnóstico por imagen , Vesícula Biliar/efectos de los fármacos , Vesícula Biliar/fisiología , Humanos , Masculino , Estudios Prospectivos , Purinas , Valores de Referencia , Citrato de Sildenafil , Sulfonas , Ultrasonografía
18.
Turk J Gastroenterol ; 17(4): 313-5, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17205414

RESUMEN

We report a 55-year-old man with a white plaque-like lesion 4 mm in diameter located in the rectum on colonoscopic examination. Biopsy specimens showed carcinoid tumor. Endoscopic submucosal resection (ESMR) of the lesion was successfully performed by using cap aspiration-snare resection method.


Asunto(s)
Tumor Carcinoide/cirugía , Proctoscopía/métodos , Neoplasias del Recto/cirugía , Humanos , Ligadura/instrumentación , Masculino , Persona de Mediana Edad
19.
Croat Med J ; 46(4): 613-8, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16100765

RESUMEN

AIM: To assess the risk factors for deaths and injuries caused by earthquakes in a high-risk earthquake zone. METHODS: A cross-sectional study was carried out in Eber town, Cay County, following the earthquake of February 3, 2002 in Afyon, Turkey. This area was particularly affected by the earthquake, with high number of casualties, including many fatalities. The study included 812 persons living in Eber at the time of the earthquake. The study population was interviewed at their homes to obtain information on the deaths and non-fatal injuries, along with potential risk factors for death and injuries. These included the type and degree of the damage to the building, precise location and the initial actions of victims at the moment of the earthquake, and socio-demographic data. RESULTS: Earthquake-related mortality rate was 16 per 1,000 people, injury rate was 22 per 1,000 people, and death/injury ratio was 1:1.4. During the earthquake, 60% of the buildings collapsed or were heavily damaged. Risk factors for death and injury were higher among those who lived in collapsed or heavily damaged buildings, wooden type buildings, or those who were near the outer walls during the earthquake. CONCLUSION: The most important risk factor for earthquake-induced mortality and morbidity was the degree of damage to the building. Another important risk factor was the location of the individual inside the room at the time of the quake.


Asunto(s)
Desastres , Mortalidad , Heridas y Lesiones/etiología , Estudios Transversales , Humanos , Factores de Riesgo , Turquía/epidemiología
20.
J Endourol ; 18(3): 245-9, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15225389

RESUMEN

BACKGROUND AND PURPOSE: Pneumoretroperitoneum (Prp) acts as an ischemia/reperfusion (I/R) model. Ischemia/reperfusion (I/R) injury causes production of reactive oxygen species, which affect organs remote from the sites of I/R. The aim of this study was to assess the remote organ changes after Prp and to explore the effects of antioxidants. MATERIALS AND METHODS: Eighteen adult rabbits were randomized to three groups, each consisting of six rabbits. Group I (control) underwent balloon dissection of the left retroperitoneal space without gas insufflation. In group II (Prp), carbon dioxide at 10 mm Hg was applied for 2 hours after the balloon dissection (ischemia period) and for 1 hour after desufflation (reperfusion period). In group III (Prp + antioxidant), 5 minutes before the experiment, verapamil at 0.2 mg/kg was given intravenously and the same procedure was employed as in group II. Hepatic, pulmonary, opposite kidney, and treated kidney malondialdehyde (MDA) and reduced glutathione (GSH) levels were evaluated to show response to Prp. RESULTS: Pneumoretroperitoneum exerted oxidative stress on all tissues with an increase of MDA (P < 0.05) and a decrease of GSH (P < 0.05). The verapamil-treated group showed lower values of MDA (P < 0.05) and higher values of GSH (P < 0.05) than group II. CONCLUSION: Pneumoretroperitoneum increased oxidative stress in all remote organs tested. Verapamil reduced the oxidative stress. We concluded that Prp should be employed carefully in patients with limited vital organ capacity. Verapamil administration may be considered for protection against tissue injury attributable to oxidative stress in these patients.


Asunto(s)
Antioxidantes/farmacología , Dióxido de Carbono/farmacología , Radicales Libres/metabolismo , Gases/farmacología , Estrés Oxidativo/efectos de los fármacos , Verapamilo/farmacología , Animales , Masculino , Modelos Animales , Neumoperitoneo/complicaciones , Neumoperitoneo/metabolismo , Conejos , Daño por Reperfusión/prevención & control , Espacio Retroperitoneal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...